Press Releases Statement: Inspector General’s Decision To Investigate FDA’s Inappropriately Close Collaboration With Biogen on the Alzheimer’s Disease Drug Aducanumab Is Long Overdue August 4, 2021
States, Medical Regulators and Institutions Must Act to End Sexual Abuse of Patients by Physicians in the U.S. August 1, 2021
Press Releases Letter: Woodcock Must Be Investigated as Part of IG’s Probe Into Aducanumab’s Approval July 13, 2021
Press Releases Statement: Woodcock’s Role in Aducanumab’s Approval Must be Investigated as Part of IG Probe July 9, 2021